Sinergium Biotech Deal History & Licensing Activity
Sinergium Biotech is a life sciences. Over the past three years, Sinergium Biotech has been involved in 7 licensing and acquisition transactions, with a primary focus on mRNA (10 deals).
Deals (12mo)
3
Active Trials
0
Top Modality
mRNA
Focus Area
Infectious Disease
Sinergium Biotech Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sinergium Biotech in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| H5N1 mRNA vaccine (WHO mRNA Technology Transfer Programme) | WHO/MPP | mRNA | Preclinical | collaboration | Jun 2025 |
| H5N1 mRNA vaccine | WHO/MPP/PAHO | mRNA | Preclinical | collaboration | Jun 2025 |
| H5N1 mRNA vaccine | WHO/PAHO/MPP | mRNA | Preclinical | collaboration | Jun 2025 |
Sinergium Biotech Pipeline Focus
Therapeutic areas and modalities where Sinergium Biotech is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Sinergium Biotech's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sinergium Biotech Licensing & Deal Activity
Sinergium Biotech is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 7 deals over the past three years, Sinergium Biotech ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sinergium Biotech include Infectious Disease (10 deals and trials). In terms of modality, Sinergium Biotech has shown particular interest in mrna.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sinergium Biotech and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sinergium Biotech's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.